Zai Long Term Investments vs Capital Surpluse Analysis
ZLAB Stock | USD 28.09 1.66 6.28% |
Zai Lab financial indicator trend analysis is more than just analyzing Zai Lab current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zai Lab is a good investment. Please check the relationship between Zai Lab Long Term Investments and its Capital Surpluse accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.
Long Term Investments vs Capital Surpluse
Long Term Investments vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zai Lab Long Term Investments account and Capital Surpluse. At this time, the significance of the direction appears to have strong relationship.
The correlation between Zai Lab's Long Term Investments and Capital Surpluse is 0.69. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Zai Lab, assuming nothing else is changed. The correlation between historical values of Zai Lab's Long Term Investments and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Zai Lab are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Long Term Investments i.e., Zai Lab's Long Term Investments and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.69 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Long Term Investments
Long Term Investments is an item on the asset side of Zai Lab balance sheet that represents investments Zai Lab intends to hold for over a year. Zai Lab long term investments may include different instruments such as stocks, bonds, real estate and cash.Capital Surpluse
Most indicators from Zai Lab's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zai Lab current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.At present, Zai Lab's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 1.49, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 3.4M | 14.6M | 16.8M | 17.6M | Depreciation And Amortization | 12.6M | 17.7M | 9.0M | 6.7M |
Zai Lab fundamental ratios Correlations
Click cells to compare fundamentals
Zai Lab Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zai Lab fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 355.2M | 1.3B | 1.6B | 1.2B | 1.0B | 754.6M | |
Other Current Liab | 10.3M | 24.0M | 46.1M | 45.5M | 58.9M | 61.8M | |
Total Current Liabilities | 46.6M | 98.0M | 192.9M | 139.8M | 203.1M | 213.2M | |
Total Stockholder Equity | 294.7M | 1.2B | 1.4B | 1.0B | 796.1M | 623.6M | |
Other Liab | 2.9M | 16.9M | 27.5M | 21.4M | 24.6M | 25.8M | |
Net Tangible Assets | 285.9M | 1.2B | 1.4B | 1.0B | 1.2B | 1.3B | |
Property Plant And Equipment Net | 36.9M | 47.1M | 58.3M | 78.8M | 68.7M | 39.8M | |
Net Debt | (54.2M) | (423.5M) | (948.6M) | (988.1M) | (775M) | (736.3M) | |
Retained Earnings | (444.7M) | (713.6M) | (1.4B) | (1.9B) | (2.2B) | (2.1B) | |
Accounts Payable | 22.7M | 62.6M | 126.2M | 66.0M | 113.0M | 118.6M | |
Cash | 75.9M | 442.1M | 964.1M | 1.0B | 790.2M | 448.6M | |
Non Current Assets Total | 62.7M | 81.6M | 109.1M | 95.8M | 96.7M | 61.5M | |
Cash And Short Term Investments | 275.9M | 1.2B | 1.4B | 1.0B | 806.5M | 644.9M | |
Common Stock Total Equity | 3.0K | 3.5K | 4K | 5K | 5.8K | 3.0K | |
Common Stock Shares Outstanding | 87.8M | 77.7M | 93.0M | 95.8M | 96.6M | 76.3M | |
Liabilities And Stockholders Equity | 355.2M | 1.3B | 1.6B | 1.2B | 1.0B | 754.6M | |
Non Current Liabilities Total | 13.9M | 30.3M | 37.1M | 34.7M | 37.1M | 28.5M | |
Other Current Assets | 6.7M | 10.9M | 18.0M | 35.7M | 23.0M | 12.4M | |
Other Stockholder Equity | 734.7M | 1.9B | 2.8B | 2.9B | 3.0B | 1.5B | |
Total Liab | 60.5M | 128.3M | 230M | 174.5M | 240.2M | 131.0M | |
Total Current Assets | 292.5M | 1.2B | 1.5B | 1.1B | 939.6M | 693.0M | |
Accumulated Other Comprehensive Income | 4.6M | (14.5M) | (23.6M) | 25.7M | 37.6M | 39.5M | |
Intangible Assets | 8.8M | 9.4M | 9.7M | 8.4M | 16.5M | 17.3M | |
Common Stock | 3.5K | 4.1K | 5K | 6K | 6.9K | 4.2K | |
Property Plant Equipment | 36.4M | 46.9M | 57.3M | 77.4M | 89.0M | 93.4M | |
Non Currrent Assets Other | 510.2K | 743K | 803K | 2.2M | 2.3M | 2.4M | |
Other Assets | 15.1M | 110.1M | 26.5M | 3.6M | 4.1M | 3.9M | |
Long Term Investments | 2.4M | 1.3M | 15.6M | 6.4M | 9.2M | 5.5M | |
Current Deferred Revenue | 2.9M | 24.7M | 27.5M | 21.4M | 19.2M | 18.3M | |
Net Invested Capital | 301.1M | 1.2B | 1.4B | 1.0B | 796.1M | 814.3M | |
Net Working Capital | 245.8M | 1.1B | 1.3B | 984.5M | 736.5M | 759.3M | |
Short Term Debt | 10.8M | 10.4M | 11.9M | 7.1M | 14.2M | 13.5M | |
Short Long Term Debt Total | 21.8M | 18.6M | 15.5M | 20.4M | 15.2M | 17.4M | |
Net Receivables | 3.8M | 5.2M | 54.8M | 48.6M | 65.3M | 68.6M | |
Short Term Investments | 200M | 744.7M | 445M | 0.0 | 16.3M | 15.5M | |
Inventory | 6.0M | 13.1M | 19.0M | 31.6M | 44.8M | 47.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 3.647 | Quarterly Revenue Growth 0.477 | Return On Assets (0.21) | Return On Equity (0.35) |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.